Mechanisms of p53 degradation

被引:106
|
作者
Chao, Chuck C. -K. [1 ,2 ]
机构
[1] Chang Gung Univ, Coll Med, Dept Biochem & Mol Biol, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan 333, Taiwan
关键词
De-ubiquitinating enzyme; E3; ligase; Mdm2; p53; Proteasome; Ubiquitin; UBIQUITIN-PROTEIN LIGASE; PROTEASOME-MEDIATED DEGRADATION; NERVOUS-SYSTEM DEVELOPMENT; SENSITIZES CANCER-CELLS; TUMOR-SUPPRESSOR P53; IN-VIVO; REGULATE P53; TRANSCRIPTIONAL ACTIVITY; DEUBIQUITINATING ENZYME; CDT1; PROTEOLYSIS;
D O I
10.1016/j.cca.2014.08.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The tumor suppressor p53 plays various functional roles in the cell by regulating multiple regulatory signals that ensure adequate temporal and spatial responses to cellular stress. p53 is usually kept inactive due to ubiquitination by a number of E3 ubiquitin ligases that target p53 for proteasomal degradation. The ubiquitously expressed proto-oncogene Mdm2 is the major E3 ubiquitin ligase involved in this process and is critical for regulating p53 homeostasis. Ubiquitination by E3 ligases may induce cellular relocation of p53 and determine the outcome of p53-mediated stress response, including cell proliferation, apoptosis and efficacy of cancer therapy. In addition to marking p53 for proteasomal degradation, ubiquitination acts as a signal for the degradation-independent functions of p53, such as nuclear export and transcriptional activation. Importantly, the reversible nature of the ubiquitination process and the identification of de-ubiquitination enzymes acting on p53 have added yet another layer of regulatory mechanism controlling p53 activity. This review highlights our current understanding of the mechanisms underlying p53 degradation as well as the significance of the p53 pathway in response to genotoxic stress. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [21] Mechanisms That Enhance Sustainability of p53 Pulses
    Kim, Jae Kyoung
    Jackson, Trachette L.
    PLOS ONE, 2013, 8 (06):
  • [22] Autoantibody recognition mechanisms of p53 epitopes
    Phillips, J. C.
    PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2016, 451 : 162 - 170
  • [23] Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein
    Ozeki, Chikako
    Sawai, Yuichiro
    Shibata, Tatsuhiro
    Kohno, Takashi
    Okamoto, Koji
    Yokota, Jun
    Tashiro, Fumio
    Tanuma, Sei-ichi
    Sakai, Ryuichi
    Kawase, Tatsuya
    Kitabayashi, Issay
    Taya, Yoichi
    Ohki, Rieko
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (20) : 18251 - 18260
  • [24] Small molecule identification for the restoration of p53 pathway through p73 and by degradation of mutant p53
    Borrero, Liz J. Hernandez
    Zhao, Shengliang
    Dicker, David T.
    El-Deiry, Wafik
    CANCER RESEARCH, 2015, 75
  • [25] Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
    M M Candeias
    D J Powell
    E Roubalova
    S Apcher
    K Bourougaa
    B Vojtesek
    H Bruzzoni-Giovanelli
    R Fåhraeus
    Oncogene, 2006, 25 : 6936 - 6947
  • [26] Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
    Ljungman, M
    NEOPLASIA, 2000, 2 (03): : 208 - 225
  • [27] Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
    Candeias, M. M.
    Powell, D. J.
    Roubalova, E.
    Apcher, S.
    Bourougaa, K.
    Vojtesek, B.
    Bruzzoni-Giovanelli, H.
    Fahraeus, R.
    ONCOGENE, 2006, 25 (52) : 6936 - 6947
  • [28] A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
    Marcus J. G. W. Ladds
    Ingeborg M. M. van Leeuwen
    Catherine J. Drummond
    Su Chu
    Alan R. Healy
    Gergana Popova
    Andrés Pastor Fernández
    Tanzina Mollick
    Suhas Darekar
    Saikiran K. Sedimbi
    Marta Nekulova
    Marijke C. C. Sachweh
    Johanna Campbell
    Maureen Higgins
    Chloe Tuck
    Mihaela Popa
    Mireia Mayoral Safont
    Pascal Gelebart
    Zinayida Fandalyuk
    Alastair M. Thompson
    Richard Svensson
    Anna-Lena Gustavsson
    Lars Johansson
    Katarina Färnegårdh
    Ulrika Yngve
    Aljona Saleh
    Martin Haraldsson
    Agathe C. A. D’Hollander
    Marcela Franco
    Yan Zhao
    Maria Håkansson
    Björn Walse
    Karin Larsson
    Emma M. Peat
    Vicent Pelechano
    John Lunec
    Borivoj Vojtesek
    Mar Carmena
    William C. Earnshaw
    Anna R. McCarthy
    Nicholas J. Westwood
    Marie Arsenian-Henriksson
    David P. Lane
    Ravi Bhatia
    Emmet McCormack
    Sonia Laín
    Nature Communications, 9
  • [29] Living with p53, dying of p53
    Aylon, Yael
    Oren, Moshe
    CELL, 2007, 130 (04) : 597 - 600
  • [30] A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
    Ladds, Marcus J. G. W.
    van Leeuwen, Ingeborg M. M.
    Drummond, Catherine J.
    Chu, Su
    Healy, Alan R.
    Popova, Gergana
    Fernandez, Andres Pastor
    Mollick, Tanzina
    Darekar, Suhas
    Sedimbi, Saikiran K.
    Nekulova, Marta
    Sachweh, Marijke C. C.
    Campbell, Johanna
    Higgins, Maureen
    Tuck, Chloe
    Popa, Mihaela
    Safont, Mireia Mayoral
    Gelebart, Pascal
    Fandalyuk, Zinayida
    Thompson, Alastair M.
    Svensson, Richard
    Gustavsson, Anna-Lena
    Johansson, Lars
    Farnegardh, Katarina
    Yngve, Ulrika
    Saleh, Aljona
    Haraldsson, Martin
    D'Hollander, Agathe C. A.
    Franco, Marcela
    Zhao, Yan
    Hakansson, Maria
    Walse, Bjorn
    Larsson, Karin
    Peat, Emma M.
    Pelechano, Vicent
    Lunec, John
    Vojtesek, Borivoj
    Carmena, Mar
    Earnshaw, William C.
    McCarthy, Anna R.
    Westwood, Nicholas J.
    Arsenian-Henriksson, Marie
    Lane, David P.
    Bhatia, Ravi
    McCormack, Emmet
    Lain, Sonia
    NATURE COMMUNICATIONS, 2018, 9